SCHEMBL3819746

SCHEMBL3819746

CN1C(=O)c2cccc(Oc3cccc4c3C(=O)N(C)C4=O)c2C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
USP2 O75604 3/20 0.51
CASP1 P29466 2/20 0.51
BRCA1 P38398 1/20 0.51
CASP7 P55210 1/20 0.51
PRMT1 Q99873 1/20 0.47
CASP3 P42574 1/20 0.47
HPGD P15428 4/20 0.46
MAPT P10636 2/20 0.46
KEAP1 Q14145 2/20 0.46
NFE2L2 Q16236 2/20 0.46
ATM Q13315 1/20 0.46
TYMS P04818 1/20 0.44
POLB P06746 1/20 0.43
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 4/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23544074 0.85 MEN1 (0.49) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL3822964 0.84 SMN1; SMN2 (0.61) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL19927865 0.82 ALDH1A1 (0.44) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL11077691 0.82 ALDH1A1 (0.44) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL10837518 0.80 MEN1 (0.44) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL28292184 0.77 MAPT (0.55) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL14819082 0.77 ALDH1A1 (0.41) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL9397268 0.77 PRMT1 (0.55) MEN1KMT2AUSP2CASP1BRCA1
SCHEMBL261965 0.77 ALDH1A1 (0.39) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL2036747 0.76 MEN1 (0.58) MEN1KMT2AUSP2CASP1BRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119327490-A Solid alkali KF/gamma-Al2O3Preparation method and application of catalyst 河北工业大学 2025-01-21 CN claimed
CN-115780487-B Extractant and method for treating solid waste in 4,4' -diphenyl ether dianhydride production by using extractant 河北东丽新材料有限公司 2023-05-05 CN claimed
CN-115780487-A Extracting agent and method for treating solid waste in 4,4' -diphenyl ether dianhydride production by using same 河北东丽新材料有限公司 2023-03-14 CN claimed
CN-112724111-B Method for preparing ODPA 浙江清和新材料科技有限公司 2022-11-29 CN claimed
CN-113912240-B Extracting agent and method for treating 4,4' -diphenyl ether dianhydride production wastewater by using same 河北海力香料股份有限公司 2022-03-15 CN claimed
CN-112724111-A Method for preparing ODPA 浙江清和新材料科技有限公司 2021-04-30 CN claimed
CN-112707879-A Method for preparing oxo-bis- (N-methylphthalimide) 浙江清和新材料科技有限公司 2021-04-27 CN claimed
EP-2097375-B1 METHOD FOR PURIFYING BISIMIDES SABIC INNOVATIVE PLASTICS IP (NL) 2013-04-24 EP claimed
EP-2097375-A1 METHOD FOR PURIFYING BISIMIDES Sabic Innovative Plastics IP B.V. (NL) 2009-09-09 EP claimed
US-7408070-B2 Method for purifying bisimides SABIC INNOVATIVE PLASTICS IP B.V. (US) 2008-08-05 US claimed
WO-2008063208-A1 METHOD FOR PURIFYING BISIMIDES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-05-29 WO claimed
US-20070073063-A1 Method for purifying bisimides GENERAL ELECTRIC COMPANY (US) 2007-03-29 US claimed
CN-115990389-B Treatment method of waste gas produced by 3,3', 4' -diphenyl ether tetracarboxylic dianhydride 河北东丽新材料有限公司 2026-05-12 CN disclosed
CN-119327490-A Solid alkali KF/gamma-Al2O3Preparation method and application of catalyst 河北工业大学 2025-01-21 CN disclosed
CN-119327490-A Solid alkali KF/gamma-Al2O3Preparation method and application of catalyst 河北工业大学 2025-01-21 CN disclosed
CN-116328479-A Treatment method of mixed gas generated in process of synthesizing 3,3', 4' -diphenyl ether dianhydride 河北海力恒远新材料股份有限公司 2023-06-27 CN disclosed
WO-2004092116-A1 BICYCLIC COMPOUNDS HAVING BRADYKININ RECEPTORS AFFINITY AND PHARMACEUTICAL COMPOSITIONS THEREOF AMGEN, INC. (US) 2004-10-28 WO disclosed
EP-0250981-B1 METHOD FOR MAKING BISIMIDES GENERAL ELECTRIC COMPANY (US) 1992-03-11 EP disclosed
US-4933469-A Method for preparing oxybisphthalimides GENERAL ELECTRIC COMPANY (US) 1990-06-12 US disclosed
US-4780544-A HEATING N-ORGANONITROPHTHALIMIDE IN PRESENCE OF APROTIC SOLVENT IN ALKALI METAL CARBOXYLATE GENERAL ELECTRIC COMPANY (US) 1988-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073063-A1 Method for purifying bisimides FHIT, PBRM1, TNS4 MEN1 1143/4885KMT2A 363/4885USP2 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.